Abattis Bioceuticals's total assets for Q4 2019 were C$19.26M, a decrease of -5.64% from the previous quarter. ATTBF total liabilities were C$8.59M for the fiscal quarter, a -2.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
